Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Sustained high prevalence of viral hepatitis and sexually transmissible infections among female sex workers in China: a systematic review and meta-analysis

  • Shu Su1,
  • Eric P. F. Chow2, 3,
  • Kathryn E. Muessig4, 5,
  • Lei Yuan6,
  • Joseph D. Tucker4, 7,
  • Xiaohu Zhang8, 9,
  • Jiehui Ren10,
  • Christopher K. Fairley2, 3,
  • Jun Jing9, 2Email author and
  • Lei Zhang1, 2, 3, 9Email author
BMC Infectious Diseases201616:2

https://doi.org/10.1186/s12879-015-1322-0

Received: 19 September 2015

Accepted: 12 December 2015

Published: 5 January 2016

Abstract

Background

The 1980’s economic boom has been associated with a rapid expansion of China’s sex industry over the past three decades. Consequently, the spread of sexually transmitted infections (STIs) and hepatitis infections among female sex workers (FSW) has become an important public health issue in China. This study identifies prevalence and risks of hepatitis and STIs in Chinese FSWs.

Method

Four electronic databases were searched for Chinese and English language peer-reviewed studies conducted between 01/2000-12/2011 that reported prevalence of hepatitis and STIs (excluding HIV) among Chinese FSW. Following the PRISMA guidelines, meta-analysis was used to estimate pooled prevalence and 95 % confidence intervals for each infection.

Result

Three hundred and thirty nine articles (34 in English and 305 in Chinese) investigating 603,647 FSWs in 29 Chinese provinces were included in this review. Over the period 2000–2011, the seroprevalence of active hepatitis B and hepatitis C among FSW were 10.7 % (7.3–15.5 %) and 1.0 % (0.7–1.3 %), respectively. The most prevalent STI was human papillomavirus (HPV, 27.0 % [10.1–55.1 %]), followed by herpes simplex virus-2 (HSV-2, 15.8 % [11.7–20.9 %]), chlamydia (13.7 % [12.1–15.4 %]), gonorrhoea (6.1 % [5.3–7.0 %]), syphilis (5.2 % [4.8–5.7 %]), genital warts (3.3 % [2.5–4.2 %]) and Trichomonas vaginitis (2.1 % [1.5–24.2 %]). Disease burden of both hepatitis and STI among FSW were concentrated in South Central and Southwest China. In particular, chlamydia and syphilis demonstrated a significant declining trend during the studied period (P < 0.05). Compared with the general Chinese population, FSW had significantly higher prevalence of all STIs except Trichomonas vaginitis. Further, compared to the general FSW population, HIV-positive FSW had significantly higher prevalence of syphilis, chlamydia, HSV-2 and Trichomonas vaginitis.

Conclusion

Prevalence of hepatitis and STIs remained high and mostly stable among Chinese FSW over the period of 2000–2011. Targeted STI and hepatitis surveillance and interventions should be strengthened among Chinese FSWs, especially those who are HIV-positive.

Keywords

Female sex worker Sexually transmitted infection Hepatitis China meta-analysis

Background

Every year, sexually transmitted infections (STIs) affect more than 500 million people worldwide, posing a substantial threat to sexual and reproductive health of the world population [1]. While most STIs are curable with timely diagnosis and treatment, others lead to serious long-term effects including reproductive complications and death. Furthermore, individuals infected with STIs are more likely to contract or transmit HIV, and co-infection with hepatitis can complicate the treatment for HIV [24]. In response to these concerns, the World Health Organization has recommended prevention of STIs and hepatitis as a reproductive health priority [5, 6].

The 2013 statistics from the Chinese Ministry of Health reported a rapidly rising trend in STIs since the 1979 economic reform [7, 8]. In the contexts of increasingly open attitudes toward commercial sex and higher disposable incomes, soliciting female sex workers (FSW) is increasing in China [9, 10]. Commercial sex is illegal in China and subjected to harsh publishment, FSWs who are caught are sent to detention centres. Most Chinese FSWs sell sex in concealed venues and have established their own network to avoid being detected by the police. Given their opaque characters, frequent risk sexual activities and low awareness, Chinese FSWs are regarded as a highly at-risk group for STIs [11, 12]. Hepatitis C and B are also of concern among this group mainly due to higher rates of reported drug use (for HCV) and unsafe sexual behaviours (for HBV) among FSW as compared to the general population [13, 14]. Furthermore, transmission of STIs and hepatitis through male clients of FSW may have potential adverse impacts on the broader female population [15]. The estimated prevalence of HIV, syphilis, chlamydia and gonorrhoea were all higher among clients of female sex workers than among the general population, and a systematic review conducted in 2000–2012 demonstrated an significant increase in syphilis among male clients [16].

China’s STI surveillance system routinely collects epidemic data of STIs only on syphilis and gonorrhoea. The data is collected by China CDC, but most of the data remain unpublished. Although numerous independent studies and an earlier systematic review [17] have reported STI and hepatitis infection burden among FSWs across China, these data have not been integrated to inform the overall geographic and temporal trends of STI infections among FSWs. In this study, we conducted a comprehensive data synthesis of hepatitis and STI epidemic information to inform the current disease burden, temporal trends and geographic distribution of STI infections among FSWs in China. This knowledge is important for informing HIV/STI health policies and designing evidence-based strategies for hepatitis and STI prevention among FSWs in China.

Methods

This meta-analysis was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement issued in 2009 (Checklist S1).

Literature and search strategy

We searched one English database (PubMed) and three Chinese databases (Wanfang Data, VIP Chinese Journal Database and China National Knowledge Infra-structure) for studies conducted between January 1, 2000 to December 31, 2011 that reported the prevalence of STIs or hepatitis infections among FSW in mainland China.

The search included Medical Subject Headings (MeSH) terms for ‘China’, ‘Chinese’, ‘CSW (commercial sex workers)’, ‘FSW’, ‘hepatitis’, ‘sexually transmitted diseases’ and ‘sexually transmitted infections’, and other keywords associated with each STI: ‘chlamydia’, ‘Chlamydia trachomatis’, ‘gonorrhoea’, ‘Neisseria gonorrhoea’, ‘syphilis’, ‘genital warts’, ‘hepatitis’, ‘HBV’, ‘hepatitis B’, ‘HCV’, ‘hepatitis C’, ‘HSV’, ‘herpes simplex virus’, ‘HPV’, ‘human papillomavirus’ and ‘trichomonas vaginitis’. Hand searching from the reference lists of the retrieved articles in the above databases was also included. Only articles published in Chinese or English language were included. Two reviewers (EPFC, XHZ) independently screened all retrieved abstracts from the four aforementioned databases to assess eligibility. Discrepancies were resolved by discussion with a third reviewer (LZ).

Selection criteria

Type of studies

Eligible study designs included quantitative epidemiological studies, including cohort and cross-sectional studies. The following types of publications were excluded: news reports, review articles, conference abstracts, mathematical modelling studies, clinical case studies, dissertations, studies with sample size less than 30 for general FSW or less than 10 for HIV-positive FSW, and STI prevalence reported without authenticated diagnosis (syphilis and hepatitis prevalence without serological test). Studies not conducted in mainland China were excluded.

Type of participants

We only included studies with FSW who self-reported having any commercial sexual activity (sell sex for money) in the past 12 months. There were no restrictions on age, marital status, educational level, ethnicity or residency. Studies that targeted HIV-positive FSW were included to investigate the prevalence of co-infection.

Type of outcome measures

We included studies that measured the prevalence of the most common STIs among FSW including syphilis, chlamydia, gonorrhoea, HPV/genital warts, HSV-2, and Trichomonas vaginitis. We also included HBV infection which is sexually transmitted and HCV infection which can be transmitted through injecting drug use. Studies were included if syphilis, chlamydia, gonorrhoea, HPV/genital warts, HSV-2, Trichomonas vaginitis, HBV or HCV was diagnosed and confirmed by a serological testing approach. We included published studies in which HBV infection was defined by the presence of hepatitis B surface antigen (HBsAg) as HBsAg is a serologic marker representing either acute or chronic HBV infection rather than due to other cases such as HBV immunity; HCV infection was diagnosed by the presence of anti-HCV antibodies; HPV infection was tested by PCR for any of the genital HPV types; chlamydia, gonorrhoea were tested by PCR, EIA or cell culture; syphilis was tested by specific treponemal serological method, rapid plasma regain or PCR and any positive result was considered positive; Trichomonas vaginitis was tested by wet mount and PCR; genital warts were clinically diagnosed based on the presence of warts; HSV-2 was diagnosed by the presence of type specific Immunoglobulin G (IgG) by EIA. Self-reported infections were excluded from this review.

Quality assessment

The authors assessed the methodological quality of every included study using an 8-item checklist tool for observational studies [18]. Based on the checklist guidelines, the quality of each item was categorized as either “High quality” (1 point) or “Low quality” (0 points) for a total possible score ranging between 0 and 8. Studies with higher scores were regarded as higher quality.

Data extraction

Data were exported and entered into a Microsoft Excel database (Version 2010, Microsoft Corp., Redmond, WA, USA). Each study was given a unique ID number and the data collection form included information on: (1) Study design: location, sampling methods/venues, type of study, sample size, and study year; (2) epidemiology of STIs and hepatitis infections: prevalence estimates of STIs, HBV or HCV, prevalence estimates of HPV gene type subgroups and prevalence estimates of sites and biomarkers of chlamydia and gonorrhoea.

Statistical analysis

Pooled estimates with 95 % confidence intervals (CI) were calculated for the prevalence of each STI and hepatitis infection among Chinese FSW. These estimates were expressed as a percentage (number of infections divided by the number of individuals tested for the infection). Pooled odds ratios (OR) with 95 % CIs were calculated by comparing the pooled estimates between FSW and the general Chinese adult population. To obtain STI prevalence for various subgroups, we also conducted sensitivity analyses, and stratified by geographic region (North, Northeast, Northwest, East, South Central, Southwest), FSW venue type (entertainment venues, national sentinel sites, detaining education centres, VCT and others), sample size, language of the publication, study quality score, and study year (Additional file 1: Table S1 and S3). To estimate the risk of STI acquisition in HIV-positive FSW, the pooled OR with a 95 % CI was calculated by comparing the pooled STI prevalence estimates among HIV-positive FSW and general FSW. STI and hepatitis prevalence of the general population was estimated for the Chinese population of reproductive age (i.e. >15 years old) using data from national or large cross-sectional studies [1924].

Heterogeneity across included studies was assessed using a chi-squared based Cochran’s Q test and an I 2 test. If the data showed low heterogeneity (p > 0.05, I 2  < 50 %), a fixed-effect model was used; otherwise, a random-effect model was used. Publication bias was tested by the Begg and Mazumdar rank correlation [25]. Geographical regions with first and second highest prevalence were defined as ‘high prevalence’ areas, the third and fourth ones were defined as ‘moderate prevalence’ whereas the fifth and sixth ones were defined as ‘low prevalence’ (Fig. 1b). The temporal trend of STIs was tested by chi-square trend test comparing the study periods 2000–2002, 2003–2005, 2006–2008, and 2009–2011 (Fig. 3). All meta-analyses were performed by using the Comprehensive Meta-Analysis (version 2.2, Biostat, Englewood, New Jersey).
Fig. 1

a. Estimated prevalence of sexually transmitted infections including Hepatitis B and C virus among female sex workers in six Chinese regions during 2000–2011. *Only infection with > 10 papers were included, so the analysis excluded HPV because there are only four papers being found. b. Level of disease burden among female workers across the six regions in China during 2000–2011 (high, moderate and low prevalence represent the top, middle and bottom one-third of prevalence ranking among the six Chinese regions). *Only infection with > 10 papers were included, so the analysis excluded HPV because there are only four papers being found

Results

Characteristics of the studies

Out of the 3015 studies identified through initial searches, 339 studies (English: 34; Chinese: 305) were eligible and included in this review (Additional file 2). The majority of studies were cross-sectional observational studies (n = 286). Eighteen studies reported on HBV, 97 on HCV, 215 on syphilis, 96 on chlamydia, 116 on gonorrhoea, 38 on HSV-2, 43 on Trichomonas vaginitis, 68 on genital warts and 4 on HPV, respectively (Table 1). From these published studies, 603,647 FSWs in 29 Chinese provinces were included in this review. Sample size ranged from 11 to 12,363. The mean age of FSW was 24.2 ± 2.4, the average length of time working in commercial sex was 2.4 years. The estimated percentage of FSW who were married was 35.3 %, and 76.9 % had only completed junior middle school education or below.
Table 1

Comparison of sexually transmitted infections prevalence between female sex workers and general female population in China

Type of infection

No. of studies (No. of data points)

Total No of infection/Sample size

Pooled prevalence among FSW (95 % CI)

Background prevalence among general population (95 % CI)

Odds ratio (95 % CI)

HBV

18 (24)

848/7,614

10.71 (7.30–15.48)

6.40 (4.45–9.08)* [26]

1.75 (1.60–1.92)

HCV

97 (149)

1,366/114,722

0.96 (0.73–1.25)

0.12 (0.05–0.27)* [20]

7.99 (3.58–17.83)

Syphilis

215 (377)

13,507/245,455

5.24 (4.83–5.69)

0.37 (0.20–0.65)* [21]

14.89 (10.86–20.40)

HSV-2

38 (57)

9,529/30,345

15.77 (11.74–20.85)

5.80 (3.82–7.78)* [22]

3.05 (2.12–4.39)

Trichomonas vaginitis

43 (65)

2,271/24,381

2.12 (1.46–24.21)

2.52 (1.92–3.31)** [22]

0.83 (0.51–1.35)

Chlamydia

96 (125)

7,983/56,548

13.66 (12.11–15.37)

2.60 (1.60–4.10)** [23]

5.95 (4.42–8.01)

 Cervix

41 (78)

5,503/33,231

13.56 (11.65–15.73)

--

--

 Vaginal

3 (4)

402/872

36.80 (19.56–58.23)

--

--

 PCR

48 (74)

5,839/31,695

15.48(13.70–17.45)

--

--

 Rapid test

16 (19)

2,144/24,853

10.28(8.20–12.83)

--

--

Gonorrhea

116 (149)

3,723/62,430

6.07 (5.29–6.95)

0.16 (0.06–0.39)** [23]

40.32 (12.99–125.18)

 Cervix

51 (74)

2,523/33,493

6.88 (5.68–8.31)

--

--

 Vaginal

7 (9)

311/1,806

12.69 (7.52–20.60)

--

--

 PCR

28 (55)

2,015/23,179

8.33(6.83–10.13)

--

--

 Culture

52 (64)

1,417/28,143

5.62(4.51–6.97)

--

--

Wart

68 (76)

1,111/39,862

3.27 (2.53–4.21)

0.06 (0.01–0.07)** [20]

52.96 (26.42–106.15)

HPV (any)

4 (4)

531/1,631

27.04 (10.07–55.09)

16.80 (16.50–17.10)** [24]

1.84 (1.64–2.06)

Gene type 16

3 (3)

142/1,143

14.08 (4.13–38.40)

3.62 (0.82–14.62)* [61, 62]

4.39 (3.20–6.03)

 Gene type 52

3 (3)

150/1,143

12.53 (6.36–23.30)

2.62 (1.75–3.48)* [61, 62]

5.32 (3.72–7.63)

 Gene type 58

2 (2)

115/1,098

12.12 (2.65–41.11)

1.59 (1.07–2.36)* [61, 62]

8.60 (5.53–13.38)

 Gene type 33

3 (3)

75/1,143

8.25 (2.61–23.19)

1.04 (0.63–1.72)* [61, 62]

8.48 (4.96–14.48)

 Gene type 31

2 (2)

59/1,098

5.05 (3.84–42.25)

2.09 (1.44–3.02)* [61, 62]

2.46 (1.58–3.82)

 Multiple type

2 (2)

216/1,098

23.57 (6.08–59.47)

--

--

 Single type

2 (2)

328/1,098

29.9(27.3–32.7)

--

--

* refers to p < 0.05

** refers to p < 0.01

Disease burden of hepatitis

For studies conducted between 2000 and 2011, the estimated overall HBV and HCV prevalence among FSW were 10.7 % (95 % CI: 7.3–15.5 %) and 1.0 % (0.7–1.3 %) (Table 1). Heterogeneities across the studies were substantial (HBV, p < 0.001; I 2  = 97.1; HCV: p < 0.001; I 2  = 94.8). HBV disease burden varied substantially from 6.1 % (4.0–9.2 %) in the East to 15.5 % (9.5–24.2 %) in the South Central (Fig. 1a). No included studies reported HBV prevalence from FSW samples in the North and Northwest. In contrast, the Northwest had the lowest HCV prevalence (0.5 % [0.2–1.6 %]); while Southwest was the highest (2.0 % [1.1–3.6 %], Fig. 1a). The temporal trends of both of them were not significant (P > 0.05). Compared to the general Chinese population, FSW had notably higher risk of HBV and HCV infection (HBV: OR = 1.8 [1.6–1.9]; HCV: OR = 8.0 [3.6–17.8]) (Table 1).

Disease burden of sexually transmitted infections

Meta-analysis indicated that the most common STI among FSW was HPV, with a pooled prevalence of 27.0 % (10.1–55.1 %). Notably, genotype HPV16 (14.1 % [4.1–38.4 %]) was the most frequently identified sub-type. About 23.6 % (6.1–59.5 %) of FSW were infected with multiple HPV sub-types. HSV-2 ranked second reaching 15.8 % (11.7–20.9 %) during 2000–2011, followed by Chlamydia at 13.7 % (12.1–15.4 %). Subgroup analyses indicated that Chlamydia prevalence substantially varied by anatomical sites, ranging from 13.6 % (11.7–15.7 %) checked by cervical smear to 36.8 % (19.6–58.2 %) checked by vaginal swab. The pooled prevalence estimates of syphilis, genital warts and Trichomonas vaginitis were 5.2 % (4.8–5.7 %), 3.3 % (2.5–4.2 %) and 2.1 % (1.5–24.2 %), respectively (Additional file 1: Table S2).

Risk of STIs among FSW was far higher than in the general population. The odds ratio (OR) for having genital warts among FSW was 81.4 (40.6–163.2) compared to the general population. This was followed by gonorrhoea (OR 40.3 [13.0–125.2]) and syphilis (OR 14.9 [10.9–20.4]) (Table 1). The prevalence of STIs was also higher among HIV-infected FSW compared to boarder FSW. Based on available data among HIV-positive FSW, prevalence of HSV-2, Chlamydia, Trichomonas vaginitis and syphilis were 83.2 % (75.6–88.8 %), 20.2 % (14.3–27.7 %), 19.7 % (12.3–30.2 %) and 15.2 % (8.3–26.4 %), respectively. These corresponded to 27.2 (17.0–43.5), 2.2 (1.4–3.3), 11.5 (5.7–23.0) and 4.1 (2.8–6.0) higher risk comparing to the broader FSW population (Table 2).
Table 2

Comparison of sexually transmitted infections prevalence between HIV-positive female sex workers and general female sex workers in China

Type of infection

No. of studies (No. of data points)

Total No of infection/Sample size

Pooled prevalence among HIV-positive FSW (95 % CI)

Pooled prevalence among FSW (95 % CI)

Odds ratio (95 % CI)

Chlamydia

2 (2)

28/139

20.21 (14.33–27.72)

13.66 (12.11–15.37)

2.15 (1.42–3.26)

HSV-2

2 (2)

107/128

83.22 (75.60–88.82)

15.77 (11.74–20.85)

13.6 (8.4–22.2)

Syphilis

5 (5)

27/210

15.22 (8.26–26.36)

5.24 (4.83–5.69)

4.13 (2.83–6.02)

Trichomonas vaginitis

1 (1)

15/76

19.74 (12.26–30.20)

2.12 (1.46–24.21)

11.48 (5.73–22.99)

Temporal and geographical trend of STIs

Among sampled FSW, several STIs demonstrated a temporal declining trend. Over the study period (2000 to 2011), reports of Chlamydia declined from 16.9 % (6.6–35.1 %) in 2000–2002 to 10.7 % (7.7–14.9 %) in 2009–2011 (p = 0.02) while reports of syphilis declined from 8.4 % (4.9–14.4 %) to 4.1 % (3.2–5.5 %) (p < 0.01). The average annual decline in prevalence of chlamydia and syphilis were 9 % (1–16 %) and 2 % (0–5 %) respectively (Fig. 2). Temporal trends of other STIs did not show significant variations.
Fig. 2

Estimated temporal trend of sexually transmitted infections among female sex workers in China during 2000–2011. *Only infection with > 10 papers were included, so the analysis excluded HPV because there are only four papers being found

Southern Chinese regions had greater risk of STIs. In particular, FSW in the Southwest had high prevalence of HSV-2 (41.8 % [35.3–38.7 %]), Chlamydia (19.0 % [15.8–22.6 %]) and Trichomonas Vaginitis (11.8 % [9.1–15.2 %]) (Fig. 1a). The South Central region shared a similar disease burden of STIs as seen in the Southwest but had the highest nationwide prevalence of syphilis and genital warts (8.3 % [7.0–10.0 %] and 4.0 % [2.6–6.3 %], respectively). Prevalence of gonorrhoea among FSW was highest in the North (12.7 % [7.5–20.6 %]) and East (6.9 % [5.7–8.3 %]) regions (Fig. 1a). Overall, the prevalence of most STIs were low to moderate among FSW in the northern Chinese regions (Fig. 1b).

Heterogeneities and risk of bias

Heterogeneities were significant in most of our meta-analyses (Additional file 1: Table S2). Larger sample size (≥400) tended to result in higher prevalence estimates (in all STIs except HSV-2). Prevalence of syphilis (8.0 % [7.4–10.1 %]), Trichomonas Vaginitis (13.2 % [7.9–21.1 %]) and gonorrhoea (7.9 % [5.9–10.6 %]) were substantially higher among FSW sampled from detention centres than among those sampled from entertainment venues (p < 0.05). Study quality score was not associated with prevalence estimates for any infections except HSV-2 (Additional file 1: Table S2).

Discussion and conclusions

This meta-analysis has consistently demonstrated higher STI and viral hepatitis burden among FSWs in South Central and Southwest China compared to other Chinese regions. Compared with a previous similar systematic review [17], our study represents a significant extension in the investigation of temporal and geographical trend of STIs among FSW in reference to the general population. Apart from chlamydia and syphilis, prevalence levels of most STIs and hepatitis infections remain stable over the studied period. Compared with the general Chinese population, FSW had a significantly higher risk of STI and hepatitis infection. Similarly, HIV-positive FSW were more likely to have STIs than the broader FSW population.

Our study reported a national HBV prevalence of 10.7 % (HBsAg active) among Chinese FSW but with distinct regional differences. This prevalence level is higher than that of the general Chinese population (7.9 % in 2010, [26]) and the prevalence (7.18 %) reported by China CDC in 2006 [27]. Among all Chinese regions, the finding that South Central China (15.5 %) has shown the highest prevalence is consistent with the prevalence in the general Chinese population [13, 19]. HBV transmission in China is primarily through mother-to-child transmission [28, 29], but transmission by sex and injection sharing has also been reported in high-risk population groups [29]. The high HBV disease burden in Southern China is likely due to earlier onset of both the epidemic [3032]. Also of note, China’s national HBV vaccination programme for newborns was only introduced in 1992 [33]; many of our studied subjects (average age 24.2) may have been born before the start or scale-up of the vaccination program. Vertical transmission may be the dominant route of transmission of HBV in FSW, but high risk sexual behaviours of FSW has also substantially added to the risk of HBV infection in comparison with the general Chinese females. Targeted interventions, orchestrated by China CDC and local NGOs, should be implemented in FSW to improve awareness and reduce further HBV transmission via sexual means and vertical transmission.

Southwest China has reported the highest prevalence of HCV (2.0 %). Southwest China has faced illicit drug trafficking issues due to its close proximity bordering the ‘golden triangle’, a well-known area for heroin production, manufacture and distribution in Southeast Asia [13]. It hosts estimated 3 million PWID and provides 42.7 % global seizures in heroin in 2013 [34]. Prevalent injection drug use may be the underlying reason for HCV transmission among FSW given that sexual transmission via heterosexual sex is rare [14, 35]. Among FSWs who use drugs, selling sex for drugs is notably more common in southern China than others regions [36, 37]. In order to alleviate the disease burden of HCV, specialised behavioural interventions for FSW with overlapping injecting and risk sexual behaviours should be designed and implemented.

We noted a fall in the prevalence of both chlamydia and syphilis over time. The fact that both of these infections are easily treatable and no significant fall has been observed in other viral infections suggest that testing and treatment of STIs either among sex workers or the general community may be the principle factor affecting their fall. On the other hand, syphilis is one of two STIs under sentinel surveillance in China and acquiring more attention from the local CDC. Thus the variation may be attributable to policy changes related to the scaling-up of syphilis testing in pregnancy [38] and as part of the 2010–2020 syphilis control plan [39]. Building on declines in chlamydia and syphilis, continued intervention efforts are needed to achieve a decrease in viral infections as well.

HPV is the most prevalent STI among Chinese FSWs (27.0 %), as well as in the general Chinese population (16.8 %, [24]). Further, HPV prevalence among Chinese FSWs appears to be higher than that found in neighbouring countries (22.9 % in Thailand [40] and 14.4 % in Singapore [41]), a finding also true for genital warts: 3.3 % in Chinese FSW versus 0.2 % in neighbouring Vietnam [42]. Genital warts are mostly caused by infection with HPV-6 or 11 [43, 44], but more virulent types of HPV (type 16 and 18) are major risk factors for cervical cancers in Chinese women [24, 45, 46]. Co-infection with HPV is also known to facilitate the transmission of chlamydia, gonorrhoea, HSV-2 and HIV [47]. Despite the evidence that early vaccination before sexual debut dramatically reduces the risk of HPV infection, genital warts and cervical cancers among females [4850], currently there is no national HPV vaccination programme and no specific prevention method for women of reproductive age in China [51]. The majority of Chinese women (approximately 70 %) have no knowledge about HPV vaccines [52] and even lower levels of knowledge and awareness of HPV in FSW [53, 54]. Given the very high disease burden of HPV, Chinese FSW should be regarded as a priority population for HPV prevention and treatment, especially FSW who are of reproductive age.

A number of limitations should be noted. First, we reported high heterogeneities in our meta-analyses. Despite the efforts of subgroup analysis and meta-regression, significant heterogeneities were still present in subgroups. We have analysed the influences of geographical region, recruitment venue, sample size, publication language, study quality score, and year of publication. Second, statistical power in subgroup analysis was often restricted by the limited number of available studies, especially among the small number of studies from the Northeast. Third, although we only included studies diagnosed with the same methodology, the diagnostic accuracy of tests maybe improved during the study period, so part of the declining trend in prevalence may be owing to the improvement of technology. Fourth, publication bias in the publication language was significant. Fifth, the different clinical diagnostic standards of STIs and hepatitis infections may result in uncertainties in sensitivity and specificity of results.

Our findings illustrated above are consistent with previous reports [7, 5558]. We have extended the previous literature by quantifying these risks in a systematic manner to demonstrate the urgency for appropriate prevention and treatment strategies among Chinese FSW, especially those co-infected with HIV. Health resources should be aligned to address these issues. Prevalence of hepatitis infection and STIs in Chinese FSWs is high but stable during the study period 2000–2011. The high prevalence of STIs may relate to the illegal status of sex work. Ongoing research indicates that countries with either regulated or legalized sex work have seen substantial falls in the prevalence of STIs in sex workers, as a result of governments’ initiatives for wide-spread condom programs and promotion of HIV testing and treatment [59, 60]. China is unlikely to legalize sex work in the near future, therefore comprehensive interventions and HIV programs for FSWs through community-based organizations should be promoted and prioritised.

Declarations

Acknowledgements

All authors declare that they have no funding received, no current external funding sources for this study and other relationships or activities that could appear to have influenced the submitted work. The Authors would like to thank the Research Centre for Public Health, Tsinghua University for the ongoing support for this project.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University
(2)
Melbourne Sexual Health Centre, Alfred Health
(3)
Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University
(4)
The University of North Carolina Project-China
(5)
Department of Health Behaviour, Gillings School of Global Public Health at the University of North Carolina at Chapel Hill
(6)
The School of Sociology and Population Studies, Renmin University of China
(7)
London School of Hygiene and Tropical Medicine
(8)
China Food and Drug Administration Institute of Executive Development
(9)
Research Center for Public Health, School of Medicine, Tsinghua University
(10)
The School of Sociology, Tsinghua University

References

  1. Gottlieb SL, Low N, Newman LM, Bolan G, Kamb M, Broutet N. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. Vaccine. 2014;32(14):1527–35. doi:10.1016/j.vaccine.2013.07.087 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  2. Boukli NM, Shetty V, Cubano L, Ricaurte M, Coelho-Dos-Reis J, Nickens Z, et al. Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients. Clin Proteomics. 2012;9(1):11. doi:10.1186/1559-0275-9-11. [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  3. Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):305–10. doi:10.1097/COH.0b013e32833a8844 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  4. Strategy to accelerate progress towards the attainment of international development goals and targets related to reproductive health. Reproductive health matters. 2005/07/23 ed. World Health Organisation, 2005:11–8.Google Scholar
  5. Reproductive Health Strategy to Accelerate Progress Towards the Attainment of International Development Goals and Targets. World Health Organization, 2014.Google Scholar
  6. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action. Secondary Prevention and Control of Viral Hepatitis Infection: Framework for Global Action 2012. http://www.who.int/csr/disease/hepatitis/GHP_framework.pdf.
  7. Ding Y, Detels R, Zhao Z, Zhu Y, Zhu G, Zhang B, et al. HIV infection and sexually transmitted diseases in female commercial sex workers in China. J Acquir Immune Defic Syndr. 2005;38(3):314–9.PubMedGoogle Scholar
  8. Shuquan Qu WL, Choi K-H, Li R, Jiang D, Zhou Y, Tian F, et al. The Potential for Rapid Sexual Transmission of HIV in China: Sexually Transmitted Diseases and Condom Failure Highly Prevalent Among Female Sex Workers. AIDS Behav. 2002;6(3):267–75.View ArticleGoogle Scholar
  9. Zhang H, Liao M, Nie X, Pan R, Wang C, Ruan S, et al. Predictors of consistent condom use based on the Information-Motivation-Behavioral Skills (IMB) model among female sex workers in Jinan. China BMC Public Health. 2011;11:113. doi:10.1186/1471-2458-11-113. [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  10. Phariss ATD. Women and HIV/AIDS in China. Washington, DC: Freeman Chair China Studies; 2004.Google Scholar
  11. Li J, Chen XS, Merli MG, Weir SS, Henderson GE. Systematic differences in risk behaviors and syphilis prevalence across types of female sex workers: a preliminary study in Liuzhou. China Sex Transm Dis. 2012;39(3):195–200. doi:10.1097/OLQ.0b013e31823d2e2a [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  12. Chow EP, Muessig KE, Yuan L, Wang Y, Zhang X, Zhao R, et al. Risk behaviours among female sex workers in China: a systematic review and data synthesis. PLoS One. 2015;10(3):e0120595. doi:10.1371/journal.pone.0120595 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  13. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122(10):990–1003. doi:10.1016/j.puhe.2008.01.014 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  14. Wu J, Huang J, Xu D, Lu C, Deng X, Zhou X. Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong. China--a cross-sectional study BMC Public Health. 2010;10:657. doi:10.1186/1471-2458-10-657 [published Online First: Epub Date].PubMedGoogle Scholar
  15. Pan S, Parish WL, Huang Y. Clients of female sex workers: a population-based survey of China. J Infect Dis. 2011;204 Suppl 5:S1211–7. doi:10.1093/infdis/jir537 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  16. McLaughlin MM, Chow EP, Wang C, Yang LG, Yang B, Huang JZ, et al. Sexually transmitted infections among heterosexual male clients of female sex workers in China: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71394. doi:10.1371/journal.pone.0071394 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  17. Poon AN, Li Z, Wang N, Hong Y. Review of HIV and other sexually transmitted infections among female sex workers in China. AIDS Care. 2011;23 Suppl 1:5–25. doi:10.1080/09540121.2011.554519 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  18. Mh B. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2):37–9.View ArticleGoogle Scholar
  19. Chen P, Yu C, Ruan B, Yang S, Ren J, Xu W, et al. Prevalence of hepatitis B in insular regions of southeast China: a community-based study. PLoS One. 2013;8(2), e56444. doi:10.1371/journal.pone.0056444. [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  20. Dai S, Shen Z, Zha Z, Leng R, Qin W, Wang C, et al. Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province. China J Med Virol. 2012;84(1):1–5. doi:10.1002/jmv.22214 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  21. Hesketh T, Ye X, Zhu W. Syphilis in China: the great comeback. Emerg Health Threats J. 2008;1:e6. doi:10.3134/ehtj.08.006 [published Online First: Epub Date].PubMedPubMed CentralGoogle Scholar
  22. Lu F, Jia Y, Bin S, Li C, Limei S, Kristensen S, et al. Predictors for casual sex and/or infection among sexually transmitted disease clinic attendees in China. Int J STD AIDS. 2009;20(4):241–8. doi:10.1258/ijsa.2008.008290 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  23. Parish WL, Laumann EO, Cohen MS, Pan S, Zheng H, Hoffman I, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA. 2003;289(10):1265–73.PubMedView ArticleGoogle Scholar
  24. Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012;131(12):2929–38. doi:10.1002/ijc.27571 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.PubMedView ArticleGoogle Scholar
  26. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Prevalence of hepatitis B in the southeast of China: a populationbased study with a large sample size. Eur J Gastroenterol Hepatol. 2011;23(8):695–700. doi:10.1097/MEG.0b013e328347322b [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  27. Cdc C. National epidemiological investigation of HBV in China Secondary National epidemiological investigation of HBV in China. 2008. http://www.chinacdc.cn/n272442/n272530/n3246177/23316.html.Google Scholar
  28. Catherine F. Houlihana NLL, Deborah Watson-Jonesa, Karen K. Smith-McCuned, Stephen Shiboskie, Patti E. Gravittf, Jennifer S. Smithh, Louise Kuhni, Chunhui Wangi and Richard Hayes. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012;26:2211–22.Google Scholar
  29. Yao JL. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut. 1996;38 Suppl 2:S37–8.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15(Suppl):E3–6.PubMedView ArticleGoogle Scholar
  31. Ping H. [Status Analysis of epidemic trend of Hepaitis B in Guang Dong]. Chin Prev Med. 2002;3(2):105–7.Google Scholar
  32. Dai Zhi Cheng QGM. The investigation of Chinese hepatitis epidemiological. Bei Jing: Science and Technology Press; 1997.Google Scholar
  33. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis. 2009;200(1):39–47. doi:10.1086/599332 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  34. UNODC. World Drug Report. Vienna: United Nations Office on Drugs and Crime; 2015.Google Scholar
  35. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 2002;78 Suppl 1:i170–5.PubMedPubMed CentralView ArticleGoogle Scholar
  36. Lin Peng YF, Fan Zi Fan, Mai Xin Rong, Wang Ye, Liu Yong Ying, Fu Xiao Bing, Zhao Qian Qian, He Qun, Xu Rui Heng. [The qualitive analysis of injected drug users behaviours among Guang Dong]. South China J Prev Med. 2006;1:23–26.Google Scholar
  37. Pei Dong nu YB, Lai Sheng Zheng, Wang Fang Qian. [High risk behaviour investigation and syphilis infection survelliance among female sex workers and drug users in Hainan]. Chin J STD. 2002;8(3):160–61.Google Scholar
  38. Tucker JD, Hawkes SJ, Yin YP, Peeling RW, Cohen MS, Chen XS. Scaling up syphilis testing in China: implementation beyond the clinic. Bull World Health Organ. 2010;88(6):452–7. doi:10.2471/blt.09.070326 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  39. Tucker JD, Cohen MS. China’s syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis. 2011;24(1):50–5. doi:10.1097/QCO.0b013e32834204bf [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  40. Chandeying V, Garland SM, Tabrizi SN. Prevalence and typing of human papilloma virus (HPV) among female sex workers and outpatient women in southern Thailand. Sex Health. 2006;3(1):11–4.PubMedView ArticleGoogle Scholar
  41. Chan R, Khoo L, Ho TH, Koh CF, Lee IW, Yam KL, et al. A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J STD AIDS. 2001;12(3):159–63.PubMedView ArticleGoogle Scholar
  42. Lan PT, Lundborg CS, Phuc HD, Sihavong A, Unemo M, Chuc NT, et al. Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect. 2008;84(2):126–32. doi:10.1136/sti.2007.027821 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  43. Chang L, Ci P, Shi J, Zhai K, Feng X, Colombara D, et al. Distribution of genital wart human papillomavirus genotypes in China: a multi-center study. J Med Virol. 2013;85(10):1765–74. doi:10.1002/jmv.23646 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  44. Wu XL, Zhang CT, Zhu XK, Wang YC. Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City. China Virol Sin. 2010;25(1):8–17. doi:10.1007/s12250-010-3078-4 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  45. Bian ML, Cheng JY, Ma L, Cong X, Liu J, Chen Y, et al. Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening. Exp Ther Med. 2013;6(5):1332–6. doi:10.3892/etm.2013.1309 [published Online First: Epub Date].PubMedPubMed CentralGoogle Scholar
  46. Li J, Zhang D, Zhang Y, Wang X, Lin Y, Hu L. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet. 2011;112(2):131–4. doi:10.1016/j.ijgo.2010.08.010 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  47. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (London, England). 2012;26(17):2211–22. doi:10.1097/QAD.0b013e328358d908. [published Online First: Epub Date].View ArticleGoogle Scholar
  48. Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. The Lancet Infectious diseases. 2015. doi:10.1016/s1473-3099(14)71073-4 [published Online First: Epub Date].
  49. Harrison C, Britt H, Garland S, Conway L, Stein A, Pirotta M, et al. Decreased management of genital warts in young women in australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study. PLoS One. 2014;9(9):e105967. doi:10.1371/journal.pone.0105967 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  50. Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, et al. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2015;91(3):214–9. doi:10.1136/sextrans-2014-051813 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  51. Zhu FC, Chen W, Hu YM, Hong Y, Li J, Zhang X, et al. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: results from a randomized controlled trial. Int J Cancer. 2014;135(11):2612–22.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Zeng Jing GQ. Cognitive situation and health education demand of Chinese women to human papillomavirus and its vaccine. Chin Nurs Res. 2013;27(6B):1673–4.Google Scholar
  53. Hong Y, Zhang C, Li X, Lin D, Liu Y. HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health. 2013;13:696. doi:10.1186/1471-2458-13-696 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  54. Li HM, Liang GJ, Yin YP, Wang QQ, Zheng ZJ, Zhou JJ, et al. Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: implications for interventions. J Med Virol. 2012;84(5):798–803. doi:10.1002/jmv.23264 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  55. Li Y, Detels R, Lin P, Fu X, Deng Z, Liu Y, et al. Difference in risk behaviors and STD prevalence between street-based and establishment-based FSWs in Guangdong Province, China. AIDS Behav. 2012;16(4):943–51. doi:10.1007/s10461-011-0102-0 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  56. Van den Hoek A, Yuliang F, Dukers NH, Zhiheng C, Jiangting F, Lina Z, et al. High prevalence of syphilis and other sexually transmitted diseases among sex workers in China: potential for fast spread of HIV. AIDS (London, England). 2001;15(6):753–9.View ArticleGoogle Scholar
  57. Fan YG, Liu JJ, Zhang YJ, Dai SY, Li MQ, Ye DQ. HIV, other sexually transmitted infections, and risk behaviors among female sex workers in Liuzhou, China. Int J Gynaecol Obstet. 2015;128(1):18–22. doi:10.1016/j.ijgo.2014.07.024 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar
  58. Jin X, Chan S, Ding G, Wang H, Xu J, Wang G, et al. Prevalence and risk behaviours for Chlamydia trachomatis and Neisseria gonorrhoeae infection among female sex workers in an HIV/AIDS high-risk area. Int J STD AIDS. 2011;22(2):80–4.PubMedView ArticleGoogle Scholar
  59. Lee DM, Binger A, Hocking J, Fairley CK. The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne. Sex Transm Infect. 2005;81(5):434–6. doi:10.1136/sti.2004.014431 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  60. Harcourt C, Egger S, Donovan B. Sex work and the law. Sex Health. 2005;2(3):121–8.PubMedView ArticleGoogle Scholar
  61. Liu SS, Chan KY, Leung RC, Chan KK, Tam KF, Luk MH, et al. Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study. PLoS One. 2011;6(5):e19244. doi:10.1371/journal.pone.0019244 [published Online First: Epub Date].PubMedPubMed CentralView ArticleGoogle Scholar
  62. Wang X, Gu D, Lou B, Xu B, Qian F, Chen Y. Hospital-based prevalence of high-risk cervical HPV types infecting the general population and female sex workers in Huzhou. China Int J Gynaecol Obstet. 2013;120(1):37–41. doi:10.1016/j.ijgo.2012.07.019 [published Online First: Epub Date].PubMedView ArticleGoogle Scholar

Copyright

© Su et al. 2016

Advertisement